Enhancing diagnosis and treatment of CKD

17 April 2024

Webcast of livestreams

The cardiorenal benefits of SGLT2 inhibitors: Insights from across the CKD spectrum

Speaker: Prof. Per-Henrik Groop

Helsinki, Finland

Lectures

Dr. Beatriz Fernández-Fernández

Dr. Beatriz Fernández-Fernández

Madrid, Spain

Removing barriers to the treatment of CKD

Watch Lecture
Prof. Peter Rossing

Prof. Peter Rossing

Copenhagen, Denmark

Screening and diagnosis of CKD in diabetes – Successful strategies for the clinical practice

Watch Lecture
Prof. Per-Henrik Groop

Prof. Per-Henrik Groop

Helsinki, Finland

The cardiorenal benefits of SGLT2 inhibitors: Insights from across the CKD spectrum

Current Lecture
Prof. Christoph Wanner

Prof. Christoph Wanner

Würzburg, Germany

New guidelines for identification and treatment of CKD

Watch Lecture

Information on Funding



Show

These lectures are available as an EACCME-certified webcast on our platform www.nephro-symposium.org from July 03, 2024 to July 03, 2026.

Go to platform

Literature

de Boer ICH, et al. Diabetes Care 2022; 45(12):3075-3090doi: 10.2337/dci22-0027
Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group; KI Suppl 2024;105:S117-S314 doi: 10.1016/j.kint.2023.10.018
Rossing P, et al. Erratum in: Nephrol Dial Transplant. 2024 Mar 27;39(4):724doi: 10.1093/ndt/gfad009